Blue light-emitting diode phototherapy presents in vitro efficacy against distinct Leishmania species and is therapeutic against tegumentary leishmaniasis in BALB/c mice

The treatment of tegumentary leishmaniasis (TL) faces significant challenges, including drug toxicity, high costs, and the emergence of resistant strains. These limitations highlight the urgent need for novel antileishmanial agents and therapeutic strategies. This study evaluated blue light-emitting...

Full description

Saved in:
Bibliographic Details
Main Authors: Breno Luiz Pimenta, Daniela Pagliara Lage, Camila Simões de Freitas, Danniele Luciana Vale, Karolina Oliveira de Melo Falcão, Saulo Samuel Gonçalves Dias, Raquel Soares Bandeira Câmara, Isabela Amorim Gonçalves Pereira, Ana Luiza Silva, Lauro de Assis Duarte Júnior, Miguel Angel Chavez-Fumagalli, Rodrigo Fernando Bianchi, Eduardo Antonio Ferraz Coelho, André Talvani
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-05-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2025.1554051/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850279914696081408
author Breno Luiz Pimenta
Breno Luiz Pimenta
Daniela Pagliara Lage
Camila Simões de Freitas
Danniele Luciana Vale
Karolina Oliveira de Melo Falcão
Saulo Samuel Gonçalves Dias
Raquel Soares Bandeira Câmara
Isabela Amorim Gonçalves Pereira
Ana Luiza Silva
Lauro de Assis Duarte Júnior
Lauro de Assis Duarte Júnior
Miguel Angel Chavez-Fumagalli
Rodrigo Fernando Bianchi
Eduardo Antonio Ferraz Coelho
Eduardo Antonio Ferraz Coelho
André Talvani
André Talvani
author_facet Breno Luiz Pimenta
Breno Luiz Pimenta
Daniela Pagliara Lage
Camila Simões de Freitas
Danniele Luciana Vale
Karolina Oliveira de Melo Falcão
Saulo Samuel Gonçalves Dias
Raquel Soares Bandeira Câmara
Isabela Amorim Gonçalves Pereira
Ana Luiza Silva
Lauro de Assis Duarte Júnior
Lauro de Assis Duarte Júnior
Miguel Angel Chavez-Fumagalli
Rodrigo Fernando Bianchi
Eduardo Antonio Ferraz Coelho
Eduardo Antonio Ferraz Coelho
André Talvani
André Talvani
author_sort Breno Luiz Pimenta
collection DOAJ
description The treatment of tegumentary leishmaniasis (TL) faces significant challenges, including drug toxicity, high costs, and the emergence of resistant strains. These limitations highlight the urgent need for novel antileishmanial agents and therapeutic strategies. This study evaluated blue light-emitting diode (LED) phototherapy as an alternative approach to inhibit Leishmania stationary promastigotes and treat infected mammalian models. In vitro assays using Leishmania amazonensis, L. braziliensis, and L. infantum demonstrated that blue LED significantly inhibited parasite growth during and after treatment, with inhibition levels comparable to those achieved with amphotericin B (AmpB). Treatment of infected macrophages with blue LED substantially reduced infection rates and amastigote recovery across all three parasite species. Ultrastructural analyses revealed the destruction of internal organelles and alterations to the surface membranes of all Leishmania species following blue LED exposure. In in vivo experiments, L. amazonensis-infected BALB/c mice were treated with AmpB, blue LED alone, combination of blue LED plus AmpB, or saline as a control. Animals treated with blue LED, particularly in combination with AmpB, exhibited significant reductions in parasite loads in infected tissues such as lesions, spleens, livers, and draining lymph nodes, as confirmed by limiting dilution assays and qPCR. Additionally, these treatments induced a robust antileishmanial Th1-type immune response, characterized by increased production of IFN-γ, IL-12, nitrite, and IgG2a antibodies. These findings suggest that blue LED phototherapy holds promise as a potential therapeutic strategy for TL and warrants further investigation in future studies.
format Article
id doaj-art-b54486d7e2394691a53dfa81d8a2ee0f
institution OA Journals
issn 1664-3224
language English
publishDate 2025-05-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj-art-b54486d7e2394691a53dfa81d8a2ee0f2025-08-20T01:48:57ZengFrontiers Media S.A.Frontiers in Immunology1664-32242025-05-011610.3389/fimmu.2025.15540511554051Blue light-emitting diode phototherapy presents in vitro efficacy against distinct Leishmania species and is therapeutic against tegumentary leishmaniasis in BALB/c miceBreno Luiz Pimenta0Breno Luiz Pimenta1Daniela Pagliara Lage2Camila Simões de Freitas3Danniele Luciana Vale4Karolina Oliveira de Melo Falcão5Saulo Samuel Gonçalves Dias6Raquel Soares Bandeira Câmara7Isabela Amorim Gonçalves Pereira8Ana Luiza Silva9Lauro de Assis Duarte Júnior10Lauro de Assis Duarte Júnior11Miguel Angel Chavez-Fumagalli12Rodrigo Fernando Bianchi13Eduardo Antonio Ferraz Coelho14Eduardo Antonio Ferraz Coelho15André Talvani16André Talvani17Programa de Pós-Graduação em Ciências da Saúde: Infectologia e Medicina Tropical, Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte, BrazilLaboratório de Imunobiologia da Inflamação, Departamento de Ciências Biológicas, Instituto de Ciências Exatas e Biológicas (ICEB), Universidade Federal de Ouro Preto, Ouro Preto, BrazilPrograma de Pós-Graduação em Ciências da Saúde: Infectologia e Medicina Tropical, Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte, BrazilPrograma de Pós-Graduação em Ciências da Saúde: Infectologia e Medicina Tropical, Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte, BrazilPrograma de Pós-Graduação em Ciências da Saúde: Infectologia e Medicina Tropical, Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte, BrazilDepartamento de Patologia Clínica, Colégio Técnico da Universidade Federal de Minas Gerais, Belo Horizonte, BrazilDepartamento de Patologia Clínica, Colégio Técnico da Universidade Federal de Minas Gerais, Belo Horizonte, BrazilPrograma de Pós-Graduação em Ciências da Saúde: Infectologia e Medicina Tropical, Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte, BrazilPrograma de Pós-Graduação em Ciências da Saúde: Infectologia e Medicina Tropical, Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte, BrazilPrograma de Pós-Graduação em Ciências da Saúde: Infectologia e Medicina Tropical, Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte, BrazilLaboratório de Imunobiologia da Inflamação, Departamento de Ciências Biológicas, Instituto de Ciências Exatas e Biológicas (ICEB), Universidade Federal de Ouro Preto, Ouro Preto, BrazilLaboratório de Polímeros e Propriedades Eletrônicas de Materiais, Instituto de Ciências Exatas e Biológicas (ICEB), Universidade Federal de Ouro Preto, Ouro Preto, BrazilComputational Biology and Chemistry Research Group, Vicerrectorado de Investigación, Universidad Católica de Santa María, Arequipa, PeruLaboratório de Polímeros e Propriedades Eletrônicas de Materiais, Instituto de Ciências Exatas e Biológicas (ICEB), Universidade Federal de Ouro Preto, Ouro Preto, BrazilPrograma de Pós-Graduação em Ciências da Saúde: Infectologia e Medicina Tropical, Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte, BrazilDepartamento de Patologia Clínica, Colégio Técnico da Universidade Federal de Minas Gerais, Belo Horizonte, BrazilPrograma de Pós-Graduação em Ciências da Saúde: Infectologia e Medicina Tropical, Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte, BrazilLaboratório de Imunobiologia da Inflamação, Departamento de Ciências Biológicas, Instituto de Ciências Exatas e Biológicas (ICEB), Universidade Federal de Ouro Preto, Ouro Preto, BrazilThe treatment of tegumentary leishmaniasis (TL) faces significant challenges, including drug toxicity, high costs, and the emergence of resistant strains. These limitations highlight the urgent need for novel antileishmanial agents and therapeutic strategies. This study evaluated blue light-emitting diode (LED) phototherapy as an alternative approach to inhibit Leishmania stationary promastigotes and treat infected mammalian models. In vitro assays using Leishmania amazonensis, L. braziliensis, and L. infantum demonstrated that blue LED significantly inhibited parasite growth during and after treatment, with inhibition levels comparable to those achieved with amphotericin B (AmpB). Treatment of infected macrophages with blue LED substantially reduced infection rates and amastigote recovery across all three parasite species. Ultrastructural analyses revealed the destruction of internal organelles and alterations to the surface membranes of all Leishmania species following blue LED exposure. In in vivo experiments, L. amazonensis-infected BALB/c mice were treated with AmpB, blue LED alone, combination of blue LED plus AmpB, or saline as a control. Animals treated with blue LED, particularly in combination with AmpB, exhibited significant reductions in parasite loads in infected tissues such as lesions, spleens, livers, and draining lymph nodes, as confirmed by limiting dilution assays and qPCR. Additionally, these treatments induced a robust antileishmanial Th1-type immune response, characterized by increased production of IFN-γ, IL-12, nitrite, and IgG2a antibodies. These findings suggest that blue LED phototherapy holds promise as a potential therapeutic strategy for TL and warrants further investigation in future studies.https://www.frontiersin.org/articles/10.3389/fimmu.2025.1554051/fullblue LED phototherapytegumentary leishmaniasistreatmentamphotericin Bimmune responseantileishmanial activity
spellingShingle Breno Luiz Pimenta
Breno Luiz Pimenta
Daniela Pagliara Lage
Camila Simões de Freitas
Danniele Luciana Vale
Karolina Oliveira de Melo Falcão
Saulo Samuel Gonçalves Dias
Raquel Soares Bandeira Câmara
Isabela Amorim Gonçalves Pereira
Ana Luiza Silva
Lauro de Assis Duarte Júnior
Lauro de Assis Duarte Júnior
Miguel Angel Chavez-Fumagalli
Rodrigo Fernando Bianchi
Eduardo Antonio Ferraz Coelho
Eduardo Antonio Ferraz Coelho
André Talvani
André Talvani
Blue light-emitting diode phototherapy presents in vitro efficacy against distinct Leishmania species and is therapeutic against tegumentary leishmaniasis in BALB/c mice
Frontiers in Immunology
blue LED phototherapy
tegumentary leishmaniasis
treatment
amphotericin B
immune response
antileishmanial activity
title Blue light-emitting diode phototherapy presents in vitro efficacy against distinct Leishmania species and is therapeutic against tegumentary leishmaniasis in BALB/c mice
title_full Blue light-emitting diode phototherapy presents in vitro efficacy against distinct Leishmania species and is therapeutic against tegumentary leishmaniasis in BALB/c mice
title_fullStr Blue light-emitting diode phototherapy presents in vitro efficacy against distinct Leishmania species and is therapeutic against tegumentary leishmaniasis in BALB/c mice
title_full_unstemmed Blue light-emitting diode phototherapy presents in vitro efficacy against distinct Leishmania species and is therapeutic against tegumentary leishmaniasis in BALB/c mice
title_short Blue light-emitting diode phototherapy presents in vitro efficacy against distinct Leishmania species and is therapeutic against tegumentary leishmaniasis in BALB/c mice
title_sort blue light emitting diode phototherapy presents in vitro efficacy against distinct leishmania species and is therapeutic against tegumentary leishmaniasis in balb c mice
topic blue LED phototherapy
tegumentary leishmaniasis
treatment
amphotericin B
immune response
antileishmanial activity
url https://www.frontiersin.org/articles/10.3389/fimmu.2025.1554051/full
work_keys_str_mv AT brenoluizpimenta bluelightemittingdiodephototherapypresentsinvitroefficacyagainstdistinctleishmaniaspeciesandistherapeuticagainsttegumentaryleishmaniasisinbalbcmice
AT brenoluizpimenta bluelightemittingdiodephototherapypresentsinvitroefficacyagainstdistinctleishmaniaspeciesandistherapeuticagainsttegumentaryleishmaniasisinbalbcmice
AT danielapagliaralage bluelightemittingdiodephototherapypresentsinvitroefficacyagainstdistinctleishmaniaspeciesandistherapeuticagainsttegumentaryleishmaniasisinbalbcmice
AT camilasimoesdefreitas bluelightemittingdiodephototherapypresentsinvitroefficacyagainstdistinctleishmaniaspeciesandistherapeuticagainsttegumentaryleishmaniasisinbalbcmice
AT dannielelucianavale bluelightemittingdiodephototherapypresentsinvitroefficacyagainstdistinctleishmaniaspeciesandistherapeuticagainsttegumentaryleishmaniasisinbalbcmice
AT karolinaoliveirademelofalcao bluelightemittingdiodephototherapypresentsinvitroefficacyagainstdistinctleishmaniaspeciesandistherapeuticagainsttegumentaryleishmaniasisinbalbcmice
AT saulosamuelgoncalvesdias bluelightemittingdiodephototherapypresentsinvitroefficacyagainstdistinctleishmaniaspeciesandistherapeuticagainsttegumentaryleishmaniasisinbalbcmice
AT raquelsoaresbandeiracamara bluelightemittingdiodephototherapypresentsinvitroefficacyagainstdistinctleishmaniaspeciesandistherapeuticagainsttegumentaryleishmaniasisinbalbcmice
AT isabelaamorimgoncalvespereira bluelightemittingdiodephototherapypresentsinvitroefficacyagainstdistinctleishmaniaspeciesandistherapeuticagainsttegumentaryleishmaniasisinbalbcmice
AT analuizasilva bluelightemittingdiodephototherapypresentsinvitroefficacyagainstdistinctleishmaniaspeciesandistherapeuticagainsttegumentaryleishmaniasisinbalbcmice
AT laurodeassisduartejunior bluelightemittingdiodephototherapypresentsinvitroefficacyagainstdistinctleishmaniaspeciesandistherapeuticagainsttegumentaryleishmaniasisinbalbcmice
AT laurodeassisduartejunior bluelightemittingdiodephototherapypresentsinvitroefficacyagainstdistinctleishmaniaspeciesandistherapeuticagainsttegumentaryleishmaniasisinbalbcmice
AT miguelangelchavezfumagalli bluelightemittingdiodephototherapypresentsinvitroefficacyagainstdistinctleishmaniaspeciesandistherapeuticagainsttegumentaryleishmaniasisinbalbcmice
AT rodrigofernandobianchi bluelightemittingdiodephototherapypresentsinvitroefficacyagainstdistinctleishmaniaspeciesandistherapeuticagainsttegumentaryleishmaniasisinbalbcmice
AT eduardoantonioferrazcoelho bluelightemittingdiodephototherapypresentsinvitroefficacyagainstdistinctleishmaniaspeciesandistherapeuticagainsttegumentaryleishmaniasisinbalbcmice
AT eduardoantonioferrazcoelho bluelightemittingdiodephototherapypresentsinvitroefficacyagainstdistinctleishmaniaspeciesandistherapeuticagainsttegumentaryleishmaniasisinbalbcmice
AT andretalvani bluelightemittingdiodephototherapypresentsinvitroefficacyagainstdistinctleishmaniaspeciesandistherapeuticagainsttegumentaryleishmaniasisinbalbcmice
AT andretalvani bluelightemittingdiodephototherapypresentsinvitroefficacyagainstdistinctleishmaniaspeciesandistherapeuticagainsttegumentaryleishmaniasisinbalbcmice